VNUS Medical Tech: New Endovenous Radiofrequency Ablation Catheter shows 100% vein occlusion rate at 6 Months, faster procedure time

Co announces Prof. Dr. Thomas Proebstle of the University of Heidelberg, Germany, presented the first report of six-month follow-up clinical results from a multi-center clinical trial of the new ClosureFAST endovenous radiofrequency vein ablation catheter at last week's American Venous Forum meeting in San Diego, CA. "ClosureFAST provides the ability to deliver high-energy dosage to obtain a successful treatment but almost totally without the disturbing side effects of laser. After my first 100 cases I find these initial results very encouraging and look forward to expanding my use of this product," said Prof. Dr. Proebstle. Living up to its name, treatments with the ClosureFAST catheter resulted in an average energy delivery time of 2.2 minutes and the average procedure time was 16.4 minutes. "Feedback from physicians has been extremely positive on the performance, the speed, and the ease of use of the catheter," stated the company's Medical Director and Vice President of Clinical Research, Lian X. Cunningham, M.D., Ph.D. "In addition, ClosureFAST catheter investigators reported that the patient recovery profile has been rapid and mild as expected with radiofrequency ablation."